222 related articles for article (PubMed ID: 8800324)
1. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
Kordek R; Biernat W; Alwasiak J; Liberski PP
Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas.
Revesz T; Alsanjari N; Darling JL; Scaravilli F; Lane DP; Thomas DG
Neuropathol Appl Neurobiol; 1993 Apr; 19(2):152-8. PubMed ID: 8100356
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumours.
Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
Acta Neurochir (Wien); 1991; 109(1-2):37-41. PubMed ID: 1648862
[TBL] [Abstract][Full Text] [Related]
6. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors.
Iwata S; Nakagawa K; Harada H; Oka Y; Kumon Y; Sakaki S
Neurosurgery; 1999 Jul; 45(1):24-8; discussion 29. PubMed ID: 10414562
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of PCNA labeling index in astrocytic tumors].
Beppu T; Arai H; Kanaya H; Sasaki K
No Shinkei Geka; 1992 Dec; 20(12):1255-9. PubMed ID: 1362456
[TBL] [Abstract][Full Text] [Related]
8. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
9. PCNA and Ki-67 labelling indices in pre-irradiated and post-irradiated astrocytomas: a comparative immunohistochemical analysis for evaluation of proliferative activity.
Pierce E; Doshi R; Deane R
Mol Pathol; 1998 Apr; 51(2):90-5. PubMed ID: 9713592
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms.
Haapasalo HK; Sallinen PK; Helén PT; Rantala IS; Helin HJ; Isola JJ
J Pathol; 1993 Nov; 171(3):207-14. PubMed ID: 7903983
[TBL] [Abstract][Full Text] [Related]
11. Thallium-201 in brain tumors: relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen.
Ishibashi M; Taguchi A; Sugita Y; Morita S; Kawamura S; Umezaki N; Shigemori M; Hayabuchi N
J Nucl Med; 1995 Dec; 36(12):2201-6. PubMed ID: 8523105
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
13. PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade.
Kayaselçuk F; Zorludemir S; Gümürdühü D; Zeren H; Erman T
J Neurooncol; 2002 Apr; 57(2):115-21. PubMed ID: 12125971
[TBL] [Abstract][Full Text] [Related]
14. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
Sallinen PK; Haapasalo HK; Visakorpi T; Helén PT; Rantala IS; Isola JJ; Helin HJ
J Pathol; 1994 Dec; 174(4):275-82. PubMed ID: 7884589
[TBL] [Abstract][Full Text] [Related]
15. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
[TBL] [Abstract][Full Text] [Related]
16. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
[TBL] [Abstract][Full Text] [Related]
17. Impact of neoadjuvant chemotherapy on Ki-67 and PCNA labeling indices for esophageal squamous cell carcinomas.
Horii N; Nishimura Y; Okuno Y; Kanamori S; Hiraoka M; Shimada Y; Imamura M
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):527-32. PubMed ID: 11173150
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immunostainings for proliferating cell nuclear antigen and Ki-67 in human extraocular lesions.
Kodama T; Kawamoto K; Kono T; Shibuya Y; Setogawa T
Graefes Arch Clin Exp Ophthalmol; 1997 Dec; 235(12):767-72. PubMed ID: 9439969
[TBL] [Abstract][Full Text] [Related]
19. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study.
Klein R; Roggendorf W
Acta Neuropathol; 2001 Mar; 101(3):245-8. PubMed ID: 11307624
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of cyclin A in astrocytic tumours.
Chakrabarty A; Bridges LR
Neuropathol Appl Neurobiol; 1998 Jun; 24(3):239-45. PubMed ID: 9717190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]